Search results
TOP NEWS: AstraZeneca details mixed findings from cancer drug trials
Morningstar· 4 days agoShares in AstraZeneca rose 0.6% to 12,548.00 pence on Tuesday morning. The Cambridge-based pharmaceutical company said Imfinzi met both its primary and secondary aims in a trial on sufferers of bladder cancer.
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoFind insight on Rigel Pharmaceuticals, AstraZeneca, Merck KGaA and more in the latest Market Talks covering the Health Care sector.
LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake
Morningstar· 4 days ago"One question that everyone asks is whether last week's good news marked the finale of the Nvidia's surge to the top, and if the past three-day selloff is the beginning of a sharper downside ...
AstraZeneca posts mixed results from recent Imfinzi trials
ShareCast· 4 days agoAstraZeneca announced contrasting results from two phase three trials involving its immunotherapy...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 4 days agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
London pre-open: Stocks to edge up after mixed US session
ShareCast· 4 days agoLondon stocks were set to nudge up at the open on Tuesday following a mixed close on Wall Street.
AstraZeneca announces positive bladder cancer trial results, Landsec raises Bluewater stake
ShareCast· 4 days agoThe FTSE 100 is expected to open 13 points lower on Tuesday, having closed up 0.53% on Monday at 8,281.55. AstraZeneca announced on Tuesday that a recent trial revealed that ...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers
Reuters via Yahoo Finance UK· 4 days agoImfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen...
Britain snubs GSK as Pfizer wins RSV jab rollout contract
This Is Money· 5 days agoThe Government has snubbed a British drugs giant by choosing a blockbuster respiratory vaccine from...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 5 days ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...